Fresenius provided inadequate instructions and warnings with these products
Minneapolis, Minnesota (PRWEB) March 11, 2014
McSweeney/Langevin reports the Federal GranuFlo multidistrict litigation (MDL) has been transferred to the District of Massachusetts before U.S. District Judge Douglas P. Woodlock. McSweeney/Langevin is currently offering free consultations to anyone who suffered injury or the death of a loved one caused by the use of GranuFlo and/or NaturaLyte products during hemodialysis. McSweeney/Langeving has alleged in complaints filed in the MDL that the improper use of Granuflow/NaturaLyte has caused metabolic alkalosis in patients resulting in low blood pressure, hypokalemia, hypoxemia, hypercapnia, cardiac arrhythmia, or cardiopulmonary arrest. McSweeney/Lagevin further alleged that GranuFlo and NaturaLyte were defectively designed or manufactured and that Fresenius, the manufacturer of these dialysate products, knew or should have known of the alleged propensity of these products to cause injury and that Fresenius provided inadequate instructions and warnings with these products.
The Granuflow MDL was formed in April 2013. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428) Judge Woodlock issued a Protective Order of Confidentiality in the case on November 15, 2013. Following the order, Plaintiffs will now be able to begin to engage in written discovery and begin taking depositions of Fresenius employees.
In a September 3, 2013 order, hundreds of Massachusetts state court cases were assigned to Judge Maynard M. Kirpalani, in Middlesex County Superior Court . In a report published by Harris Martin, Judge Kirpalani stated,“The parties shall work to coordinate the conduct of this litigation with other product liability actions involving Fresenius.” Judge Kirpalanis quote implies a hope for a coordinated effort between the MDL and Massachusetts State Court Actions.
All of the MDL cases and Massachusetts State Court Cases are currently in the pretrial phase of litigation.